Needham Reiterates Trevi Therapeutics (TRVI) Buy Recommendation
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Fintel reports that on May 12, 2023, Needham reiterated coverage of Trevi Therapeutics (NASDAQ:TRVI) with a Buy recommendation.
:max_bytes(150000):strip_icc():format(jpeg)/WhatIsaRealEstateAppraiserDec.162021-ddb6a1aa97cc4f6686fd6f7ba9cfcca3.jpg "Reverse Mortgage Appraisal: What It Is, How It Works")
:max_bytes(150000):strip_icc():format(jpeg)/48126619532_f99720960b_k-4440c9ca18eb40d39353e807e7cd56ba.jpg "<div>FINRA vs. the SEC: What's the Difference?</div>")
